The role of allergen challenge chambers in the evaluation of anti‐allergic medication: an international consensus paper
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Summary: Allergic rhinitis (AR) is a common condition with quality of life and economic implications for those affected. Numerous studies have attempted to evaluate treatments for rhinitis, seeking clinically meaningful efficacy and safety results to enable evidence‐based treatment decisions. Traditional studies of medications for AR are hampered by many confounding environmental factors as well as suboptimal medication compliance. They are also an unsuitable setting for determination of precise pharmacodynamic properties of medications, including onset and duration of action. Allergen challenge chambers (ACCs) were developed to provide predetermined, controlled allergen levels and to limit variables inherent in traditional studies. An ACC hosts a number of allergen‐sensitive subjects who may receive either medication or placebo in a closed environment regulated for temperature, humidity and other variables. Subjects' allergic responses are monitored using subjective and objective assessments throughout the study, and the resultant information contributes significantly to the clinical profile of a medication. This consensus paper provides an in‐depth review of the role of ACCs as a means to evaluate treatments in AR, and concludes that ACC trials fulfil an important supportive role in the assessment of anti‐allergic medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Möller, C., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Jacobsen, L., Koivikko, A., Koller, D. Y., Niggemann, B., Norberg, L. A., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121317 · Cited by 1,065
Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis*
Wilson, D. R., Torres Lima, M., & Durham, S. R. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00699.x · Cited by 660
A comparison of Likert and visual analogue scales for measuring change in function
Guyatt, G. H., Townsend, M., Berman, L. B., & Keller, J. L. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90080-4 · Cited by 456
Economic impact and quality-of-life burden of allergic rhinitis
Schoenwetter, W. F., Dupclay, L., Appajosyula, S., Botteman, M. F., & Pashos, C. L. (2004) · Current Medical Research and Opinion · doi:10.1185/030079903125003053 · Cited by 256
Stuck, B. A., Czajkowski, J., Hagner, A.-E., Klimek, L., Verse, T., Hörmann, K., & Maurer, J. T. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.12.589 · Cited by 181
Lee, S., Wong, W., & Lau, Y. (2004) · Pediatric Allergy and Immunology · doi:10.1046/j.0905-6157.2003.00109.x · Cited by 140
Sim, T. C., Reece, L. M., Hilsmeier, K. A., Grant, J. A., & Alam, R. (1995) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.152.3.7545059 · Cited by 112
Day, J. H., Briscoe, M. P., Rafeiro, E., & Ratz, J. D. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.0117.x · Cited by 87
Self-citationKrug, N., Loedding, H., Hohlfeld, J. M., Larbig, M., Buckendahl, A., Badorrek, P., Geldmacher, H., Behnke, W., Dunkhorst, W., Windt, H., et al. (2003) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2003.01810.x · Cited by 73
Self-citation
Cited by
Patel, D., Couroux, P., Hickey, P., Salapatek, A. M., Laidler, P., Larché, M., & Hafner, R. P. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.028 · Cited by 198
“The use of an environmental exposure chamber (EEC) allows for clinical trial subjects to be exposed to aeroallergens in a highly controlled manner and allows the use of pre-established allergen levels known to induce symptoms at the moderate-to-severe level.(9,10) In a previous unrelated pilot EEC study we demonstrate…”
BackgroundHorak, F., Zieglmayer, P., Zieglmayer, R., Lemell, P., Devillier, P., Montagut, A., Mélac, M., Galvain, S., Jean-Alphonse, S., Van Overtvelt, L., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.06.006 · Cited by 175
“An ACC is a specially designed room used to expose study participants to a fixed, predetermined allergen concentration for a set period of time.(6) ACCs also allow identical repeated exposures and thus assessment of changes over time in an individual’s response.”
BackgroundSelf-citationConjunctival allergen provocation test : guidelines for daily practice
Fauquert, J.-L., Jedrzejczak-Czechowicz, M., Rondon, C., Calder, V., Silva, D., Kvenshagen, B. K., Callebaut, I., Allegri, P., Santos, N., Doan, S., et al. (2017) · Allergy · doi:10.1111/all.12986 · Cited by 126
In vivo diagnosis of allergic diseases-allergen provocation tests
Agache, I., Bilò, M., Braunstahl, G.-J., Delgado, L., Demoly, P., Eigenmann, P., Gevaert, P., Gomes, E., Hellings, P., Horak, F., et al. (2015) · Allergy · doi:10.1111/all.12586 · Cited by 104
Self-citationPatel, P., Holdich, T., Fischer von Weikersthal-Drachenberg, K. J., & Huber, B. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.032 · Cited by 98
Metadata
- Authors
- Day, J. H., Horak, F., Briscoe, M. P., Canonica, G. W., Fineman, S. M., Krug, N., Leynadier, F., Lieberman, P., Quirce, S., Takenaka, H., & Van Cauwenberge, P.
- Venue
- Clinical & Experimental Allergy Reviews
- Publisher
- Wiley
- Published
- 2006-01-31
- Volume
- 6
- Issue
- 2
- Pages
- 31-59
- ISSN
- 1472-9725 (ISSN-L)
- 1472-9733
- OpenAlex
- W2045125419
- Cited by
- 57
- References
- 16
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of allergen challenge chambers in the evaluation of anti‐allergic medication: an international consensus paper. https://app.cochat.ai/papers/10.1111/j.1365-2222.2005.00099.x
- The paper
- Day, J. H., Horak, F., Briscoe, M. P., Canonica, G. W., Fineman, S. M., Krug, N., Leynadier, F., Lieberman, P., Quirce, S., Takenaka, H., & Van Cauwenberge, P. (2006). The role of allergen challenge chambers in the evaluation of anti‐allergic medication: an international consensus paper. Clinical & Experimental Allergy Reviews. https://doi.org/10.1111/j.1365-2222.2005.00099.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.